1st Central European Conference for Advanced Therapy and Immunotherapy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F24%3A00139256" target="_blank" >RIV/00216224:14110/24:00139256 - isvavai.cz</a>
Result on the web
<a href="https://www.med.muni.cz/en/calendar/events-calendar/1st-central-european-conference-for-advanced-therapy-and-immunotherapy" target="_blank" >https://www.med.muni.cz/en/calendar/events-calendar/1st-central-european-conference-for-advanced-therapy-and-immunotherapy</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
1st Central European Conference for Advanced Therapy and Immunotherapy
Original language description
The conference brings together leading experts from academia, clinical settings and research institutions from across Central Europe to jointly address shared challenges in the field of rare diseases and advanced therapies. Leading experts in advanced therapy medicinal products (ATMPs) from the European Union make significant contributions to research throughout the entire ATMP lifecycle. The contributions in this proceedings cover several phases, from initial discovery and development to clinical trials, manufacturing, regulation and post-market surveillance. Their research addresses key challenges in the field, such as improving the efficacy, safety and scalability of gene therapies, cell therapies and tissue engineered products.
Czech name
—
Czech description
—

Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)